| 2024-10-04 | +1.29 % |
|
| 2024-10-02 | -0.98 % |
|
| 2024-10-01 | -1.1 % |
|
| 2024-09-27 | +0.9 % |
|
| 2024-09-26 | +0.3 % |
|
| 2024-09-25 | -1.66 % |
|
| 2024-09-24 | -0.31 % |
|
| 2024-09-23 | +0.09 % |
|
| 2024-08-09 | +0.3 % |
- Hologic, Inc. (NASDAQ:HOLX) stock increased by 0.3% due to positive investor sentiment driven by the company's strong financial performance, its strategic acquisition of Endomagnetics, and its anticipated revenue growth despite post-pandemic challenges.
- Hologic Inc. (NASDAQ:HOLX) has reached a new 52-week high, with stock prices rising 0.3% to $84.37 due to strong financial results, investor confidence in its growth strategies, and a robust product pipeline, particularly in women's health and diagnostics. The stock goes up because of the company's solid revenue growth, positive guidance, strategic acquisitions, and shareholder-friendly practices like share buybacks.
|
| 2024-08-06 | +0.11 % |
|
| 2024-07-31 | -1.09 % |
|
| 2024-07-08 | +0.58 % |
|
| 2024-06-12 | -2.01 % |
|
| 2024-05-31 | +1.65 % |
|
| 2024-05-29 | -1.32 % |
|
| 2024-05-23 | -1.1 % |
|
| 2024-05-21 | -0.4 % |
|
| 2024-05-20 | -0.23 % |
|
| 2024-05-17 | +0.09 % |
|
| 2024-05-16 | +0.12 % |
|
| 2024-05-09 | -0.15 % |
|
| 2024-05-03 | +0.83 % |
|
| 2024-05-02 | -0.49 % |
|
| 2024-04-30 | -1.12 % |
|
| 2024-04-29 | +0.86 % |
|
| 2024-04-24 | -0.62 % |
- Summary: abrdn plc increased its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 23.8% during the 4th quarter, leading to a rise in the company's stock value, yet HOLX stock went down due to a mix of multiple institutional investors selling and buying shares, as well as insider selling of company stock, despite positive analyst ratings and favorable earnings results for the company.
Reason for Hologic (HOLX) Stock Decline: The decrease in HOLX stock price can be attributed to a combination of institutional investors selling and buying shares of the company, as well as insider selling of company stock, despite the positive analyst ratings and favorable quarterly earnings reported by Hologic.
- The summary of the article is that Lindbrook Capital LLC increased its position in Hologic, Inc. (HOLX), while other institutional investors and hedge funds also bought shares of the company, but the stock went down by 0.62% last night. HOLX stock might have gone down due to insider selling, where directors sold over 32,000 shares valued at $2.47 million in the last three months, which could have impacted investor confidence and led to a decline in the stock price.
|
| 2024-04-19 | +0.37 % |
- The article discusses how Sentry Investment Management LLC reduced its position in Hologic, Inc. (NASDAQ:HOLX) by 9.7%, leading to an increase in institutional ownership of HOLX stock, with other institutions like Nordea Investment Management AB, Ontario Teachers Pension Plan Board, and HB Wealth Management LLC also holding shares, attributing to the stock going up partially due to positive analyst ratings and recent earnings report exceeding expectations.
- The article discusses upcoming earnings reports from major technology and growth companies like Tesla, Meta Platforms, Alphabet, and Microsoft; the reason behind Hologic's (HOLX) stock going up by 0.37% last night is not mentioned in this specific article.
- Hologic (HOLX) stock went up by 0.37%, and the overall market trend has seen selling pressure, particularly in the Tech sector, with various factors like Federal Reserve comments, interest rate expectations, and market volatility influencing investor sentiment and stock movements.
|
| 2024-04-17 | -0.25 % |
|
| 2024-04-15 | +0.27 % |
|
| 2024-04-09 | +1.33 % |
- Summary: New York State Teachers Retirement System reduced its stake in Hologic, Inc. (NASDAQ:HOLX) by 10.6%, leading the stock to rise by 1.33%; the company has received favorable ratings and price target increases from analysts following its strong quarterly earnings report.
Reason for Hologic (HOLX) stock increase: The stock went up following a positive quarterly earnings report that beat consensus estimates and showcased strong financial performance, including higher earnings per share and revenue despite a slight decrease. The company also received upgraded ratings from analysts and experienced insider selling activities.
- Summary: Hologic (HOLX) stock was up 1.33% last night after a successful Q&A session at the Needham Healthcare Conference where CFO Karleen Oberton discussed the company's strong sales growth, expanded guidance, and growth drivers in its divisions like Molecular and Surgical.
Reason for Stock Increase: Hologic's stock went up due to the positive performance reported in their fiscal first quarter, driven by strong sales growth, guidance raise, growth drivers in various divisions, successful utilization of Panther systems, and ongoing engagement with customers for menu expansion and assay contracts, despite concerns related to cervical cancer screening recommendations.
|
